KBRA announces the assignment of preliminary ratings to five classes of VRTX 2025-HQ, a CMBS single-borrower securitization. The collateral for the transaction is a $600 million portion of a $1.0 ...

ZUG, Switzerland and BOSTON, Aug. 04, 2025 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious ...

DJ Form 8.3 - The Vanguard Group, Inc.: Primary Health Properties plc The Vanguard Group, Inc. ( ) Form 8.3 - The Vanguard Group, Inc.: Primary Health Properties plc 21-Jul-2025 / 14:40 GMT/BST ...

All forms of life share a few basic attributes: They handle chemical information, metabolize some form of energy (such as consuming food or performing photosynthesis) to sustain themselves and ...

Built-to-rent properties have been touted as a possible solution to the loss of private landlords from the rented sector.

WVE-006, the leading GalNAc-RNA editing oligonucleotide designed to correct AAT protein and address both lung and liver ...

Shares of Vertex Pharmaceuticals sank 15% after the drugmaker announced a study showed its experimental pain medicine was not ...

Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $481.56, ...

I think that's the case with Vertex. Here are seven reasons why Vertex is a no-brainer stock to buy on the dip.

Vertex Pharmaceuticals Inc. fell after an experimental pain drug failed to provide post-surgery benefits and US regulators ...